Geron Ownership | Who Owns Geron?
Geron Ownership Summary
Geron is owned by 23.45% institutional investors, 0.10% insiders, and 76.45% retail investors. Ra capital management is the largest institutional shareholder, holding 9.06% of GERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Geron shares.
GERN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Geron | 23.45% | 0.10% | 76.45% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 60.38M | 9.06% | $82.72M |
| Blackrock | 46.55M | 7.71% | $197.38M |
| Blackrock funding, inc. /de | 45.91M | 6.88% | $60.61M |
| Deep track capital, lp | 41.10M | 6.17% | $56.30M |
| Vanguard group | 35.66M | 5.35% | $47.07M |
| Janus henderson group | 27.08M | 4.09% | $95.77M |
| Vivo capital | 27.23M | 4.09% | $37.30M |
| State street | 26.62M | 4.00% | $36.47M |
| Soleus capital management | 23.29M | 3.49% | $30.74M |
| Vestal point capital, lp | 17.23M | 2.59% | $23.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 500.00K | 3.89% | $685.00K |
| Stempoint capital lp | 6.65M | 3.01% | $9.38M |
| Vivo capital | 27.23M | 3.00% | $37.30M |
| Stonepine capital management | 1.60M | 1.78% | $2.19M |
| Deep track capital, lp | 41.10M | 1.57% | $56.30M |
| Boxer capital | 6.00M | 1.34% | $25.44M |
| Eversept partners, lp | 12.60M | 1.19% | $17.26M |
| Soleus capital management | 23.29M | 1.13% | $30.74M |
| Vestal point capital, lp | 17.23M | 1.07% | $23.60M |
| Ra capital management | 60.38M | 1.02% | $82.72M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 23.29M | 1.13% | 6.00M |
| Stempoint capital lp | 6.65M | 3.01% | 5.69M |
| Eversept partners, lp | 12.60M | 1.19% | 5.28M |
| Blackrock | 46.55M | 0.00% | 5.14M |
| Janus henderson group | 27.08M | 0.05% | 4.52M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | - | - | -44.11M |
| Holocene advisors, lp | - | - | -22.20M |
| Adage capital partners gp | - | - | -21.80M |
| Tcg crossover management | - | - | -17.39M |
| Bioimpact capital | - | - | -10.48M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Pale fire capital se | 2.28M | 0.34% | 2.28M | $3.13M |
| Two sigma investments, lp | 1.85M | 0.00% | 1.85M | $2.54M |
| Srs capital advisors | 1.39M | 0.03% | 1.39M | $1.93M |
| Almitas capital | 946.32K | 0.30% | 946.32K | $1.30M |
| Aquatic capital management | 437.88K | 0.01% | 437.88K | $599.89K |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -1.00 |
| True wealth design | -4.00 |
| Smartleaf asset management | -64.00 |
| Geowealth management | -96.00 |
| Nelson, van denburg & campbell wealth management group | -96.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | -53.96% | 156,418,320 | -69.15% | 23 | 0.40% | 34 | -67.62% | 40 | -55.56% |
| Sep 30, 2025 | 125 | -52.11% | 130,616,668 | -74.61% | 19 | 0.33% | 40 | -68.25% | 45 | -37.50% |
| Jun 30, 2025 | 257 | -6.20% | 514,289,584 | 0.89% | 77 | 1.32% | 125 | -10.71% | 71 | 1.43% |
| Mar 31, 2025 | 14 | -95.19% | 143,280,723 | -70.72% | 21 | 0.39% | 10 | -93.51% | 2 | -96.97% |
| Dec 31, 2024 | 123 | -53.58% | 152,695,838 | -69.98% | 23 | 0.39% | 60 | -54.89% | 24 | -58.62% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 20.05M | 3.14% | - |
| Vanguard US Total Market Shares ETF | 17.83M | 2.80% | 17.67K |
| BioPharma Credit Ord | 14.12M | 2.22% | 14.12M |
| State Street® SPDR® S&P® Biotech ETF | 14.09M | 2.21% | -75.84K |
| iShares Russell 2000 ETF | 13.01M | 2.04% | 5.60M |
| SPDR® S&P Biotech ETF | 10.09M | 1.58% | 22.55K |
| Vanguard Explorer Inv | 8.78M | 1.38% | - |
| Fidelity Select Biotechnology | 8.00M | 1.25% | - |
| Eventide Healthcare & Life Sciences I | 7.07M | 1.11% | - |
| abrdn Healthcare Investors | 6.25M | 0.98% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | $19.12K |
| May 09, 2025 | LAWLIS V BRYAN | - | Buy | $15.67K |
| Feb 27, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Buy | $24.15K |
| Feb 27, 2025 | SCARLETT JOHN A | Chairman, President and CEO | Buy | $22.06K |
| Feb 27, 2025 | Ziegler James | EVP, Chief Commercial Officer | Buy | $160.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 1 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | 3 | - |
GERN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools